Company / Return on Assets (ROA)
Cocrystal Pharma, Inc. Return on Assets (ROA) History
FY2012-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-17.9%
FY2021
5-year range
-171.9% / -17.9%
FY2017-FY2021
Trend
+79.9%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -171.9% to -17.9% over the past 2 years.
Based on SEC 10-K filings.
-17.9% in FY2021.
Improved from -171.9% to -17.9% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2021, return on assets (roa) increased 79.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score 14.87 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2021 | -17.9% | +79.9% |
| FY2020 | -88.8% | +48.3% |
| FY2019 | -171.9% | -56.3% |
| FY2012 | -110.0% | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026